Alvotech announces CEO transition
Source: SeekingAlpha
2026-01-06 08:46:46 ET
More on Alvotech
- Alvotech (ALVO) Discusses Launch of $125 Million Commercial Bond Offering and Business Update Transcript
- Alvotech (ALVO) Q3 2025 Earnings Call Transcript
- Alvotech 2025 Q3 - Results - Earnings Call Presentation
- Alvotech announces European launch of biosimilar to Simponi
- Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in U.S.
Read the full article on Seeking Alpha
For further details see:
Alvotech announces CEO transition
Alvotech
NASDAQ: ALVO
ALVO Trading
-5.86% G/L:
$3.375 Last:
372,483 Volume:
$3.54 Open:
ALVO Latest News
ALVO Stock Data
$1,569,389,520
107,654,085
N/A
30
N/A
Pharmaceuticals
Healthcare
LU
Luxembourg
